Clinical Trial: COVID-19 Antibody Responses In Cystic Fibrosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: OBSERVATIONAL
Official Title: COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF
Brief Summary:
Coronavirus disease 2019 (COVID-19) which is caused by the virus SARS-CoV-2 has resulted in an ongoing global pandemic.It is unclear whether the relatively low number of reported cases of COVID-19 in people with CF (pwCF) is due to enhanced infection prevention practices or whether pwCF have protective genetic/immune factors.This study aims to prospectively assess the proportion of pwCF, including both adults and children with CF who have evidence of SARS-CoV-2 antibodies over a two-year period.This study…
Read more